MacroGenics Price to Free Cash Flow Ratio 2012-2025 | MGNX
Historical price to free cash flow ratio values for MacroGenics (MGNX) since 2012.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| MacroGenics Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-07-02 | 1.38 | 0.00 | |
| 2025-03-31 | 1.27 | $-1.15 | 0.00 |
| 2024-12-31 | 3.25 | $-1.15 | 0.00 |
| 2024-09-30 | 3.29 | $-0.99 | 0.00 |
| 2024-06-30 | 4.25 | $-2.52 | 0.00 |
| 2024-03-31 | 14.72 | $-1.83 | 0.00 |
| 2023-12-31 | 9.62 | $-1.29 | 0.00 |
| 2023-09-30 | 4.66 | $-0.35 | 0.00 |
| 2023-06-30 | 5.35 | $0.06 | 94.52 |
| 2023-03-31 | 7.17 | $-0.72 | 0.00 |
| 2022-12-31 | 6.71 | $-1.47 | 0.00 |
| 2022-09-30 | 3.46 | $-2.90 | 0.00 |
| 2022-06-30 | 2.95 | $-2.99 | 0.00 |
| 2022-03-31 | 8.81 | $-2.95 | 0.00 |
| 2021-12-31 | 16.05 | $-2.50 | 0.00 |
| 2021-09-30 | 20.94 | $-1.79 | 0.00 |
| 2021-06-30 | 26.86 | $-1.89 | 0.00 |
| 2021-03-31 | 31.85 | $-1.84 | 0.00 |
| 2020-12-31 | 22.86 | $-2.25 | 0.00 |
| 2020-09-30 | 25.19 | $-2.85 | 0.00 |
| 2020-06-30 | 27.92 | $-2.87 | 0.00 |
| 2020-03-31 | 5.82 | $-3.11 | 0.00 |
| 2019-12-31 | 10.88 | $-2.88 | 0.00 |
| 2019-09-30 | 12.76 | $-2.83 | 0.00 |
| 2019-06-30 | 16.97 | $-3.43 | 0.00 |
| 2019-03-31 | 17.98 | $-3.81 | 0.00 |
| 2018-12-31 | 12.70 | $-4.35 | 0.00 |
| 2018-09-30 | 21.44 | $-0.82 | 0.00 |
| 2018-06-30 | 20.65 | $-0.91 | 0.00 |
| 2018-03-31 | 25.16 | $-0.60 | 0.00 |
| 2017-12-31 | 19.00 | $-0.42 | 0.00 |
| 2017-09-30 | 18.48 | $-4.01 | 0.00 |
| 2017-06-30 | 17.51 | $-1.64 | 0.00 |
| 2017-03-31 | 18.60 | $-1.63 | 0.00 |
| 2016-12-31 | 20.44 | $-1.59 | 0.00 |
| 2016-09-30 | 29.91 | $-1.58 | 0.00 |
| 2016-06-30 | 26.99 | $-3.24 | 0.00 |
| 2016-03-31 | 18.75 | $-3.07 | 0.00 |
| 2015-12-31 | 30.97 | $-0.72 | 0.00 |
| 2015-09-30 | 21.42 | $-0.68 | 0.00 |
| 2015-06-30 | 37.97 | $-0.87 | 0.00 |
| 2015-03-31 | 31.37 | $-0.19 | 0.00 |
| 2014-12-31 | 35.07 | $-1.33 | 0.00 |
| 2014-09-30 | 20.90 | $-3.02 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.079B | $0.150B |
| MacroGenics Inc. is a biopharmaceutical company. It is focused on discovering and developing innovative monoclonal antibody-based therapeutics. The Company has a diverse portfolio of product candidates focused in three therapeutic areas: oncology, autoimmune disorders and infectious diseases. MacroGenics Inc. is headquartered in Rockville, Maryland. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $237.070B | 28.51 |
| Boston Scientific (BSX) | United States | $155.016B | 38.81 |
| Stryker (SYK) | United States | $151.431B | 31.66 |
| EssilorLuxottica (ESLOY) | France | $128.578B | 0.00 |
| Medtronic (MDT) | Ireland | $113.826B | 16.14 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.396B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.515B | 26.54 |
| ResMed (RMD) | United States | $37.575B | 28.22 |
| GE HealthCare Technologies (GEHC) | United States | $34.776B | 16.51 |
| Agilent Technologies (A) | United States | $34.216B | 22.31 |
| Terumo (TRUMY) | Japan | $26.620B | 34.58 |
| Koninklijke Philips (PHG) | Netherlands | $23.303B | 16.35 |
| Insulet (PODD) | United States | $21.112B | 82.87 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.610B | 11.95 |
| Baxter (BAX) | United States | $16.026B | 11.97 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.402B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.748B | 23.48 |
| Lantheus Holdings (LNTH) | United States | $5.495B | 13.86 |
| Prestige Consumer Healthcare (PBH) | United States | $3.969B | 17.73 |
| Perrigo (PRGO) | Ireland | $3.771B | 9.56 |
| Haemonetics (HAE) | United States | $3.667B | 16.70 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.393B | 28.20 |
| ICU Medical (ICUI) | United States | $3.321B | 24.49 |
| QuidelOrtho (QDEL) | United States | $2.015B | 13.86 |
| LeMaitre Vascular (LMAT) | United States | $1.891B | 42.27 |
| AtriCure (ATRC) | United States | $1.594B | 0.00 |
| Acuren (TIC) | United States | $1.327B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.269B | 12.88 |
| Green Thumb Industries (GTBIF) | United States | $1.158B | 26.05 |
| Neogen (NEOG) | United States | $1.103B | 14.11 |
| Phibro Animal Health (PAHC) | United States | $1.079B | 13.79 |
| BioLife Solutions (BLFS) | United States | $1.029B | 0.00 |
| InMode (INMD) | Israel | $0.937B | 9.45 |
| Kestra Medical Technologies (KMTS) | United States | $0.813B | 0.00 |
| Owens & Minor (OMI) | United States | $0.728B | 6.04 |
| CeriBell (CBLL) | United States | $0.671B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.639B | 0.00 |
| Evolus (EOLS) | United States | $0.593B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.544B | 0.00 |
| Valneva SE (VALN) | France | $0.487B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.443B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.424B | 0.00 |
| Surmodics (SRDX) | United States | $0.419B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.353B | 12.98 |
| Quanterix (QTRX) | United States | $0.334B | 0.00 |
| SNDL (SNDL) | Canada | $0.321B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Cerus (CERS) | United States | $0.283B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.277B | 23.33 |
| Sanuwave Health (SNWV) | United States | $0.276B | 0.00 |
| ZimVie (ZIMV) | United States | $0.274B | 12.46 |
| Cresco Labs (CRLBF) | United States | $0.258B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.256B | 0.00 |
| Brainsway (BWAY) | Israel | $0.245B | 64.88 |
| Aurora Cannabis (ACB) | Canada | $0.242B | 71.67 |
| Biote (BTMD) | United States | $0.225B | 6.34 |
| OraSure Technologies (OSUR) | United States | $0.225B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.208B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.195B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.190B | 0.00 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.18 |
| Organigram Global (OGI) | Canada | $0.177B | 0.00 |
| Omeros (OMER) | United States | $0.174B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.141B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 16.35 |
| Jin Medical (ZJYL) | China | $0.099B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 12.50 |
| TerrAscend (TSNDF) | Canada | $0.091B | 0.00 |
| Veru (VERU) | United States | $0.086B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.086B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.081B | 0.00 |
| Zynex (ZYXI) | United States | $0.080B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.076B | 0.00 |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Agape ATP (ATPC) | $0.067B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 57.57 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.75 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |